Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

NCT00067457 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Colon
Irritable Bowel Syndrome (IBS)

Interventions

DRUG: alosetron

Sponsor

GlaxoSmithKline